Applied Therapeutics, Inc.

NasdaqGM:APLT 株式レポート

時価総額：US$1.1b

Applied Therapeutics マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Shoshana Shendelman

最高経営責任者

US$9.5m

報酬総額

CEO給与比率6.6%
CEO在任期間8.8yrs
CEOの所有権3.9%
経営陣の平均在職期間less than a year
取締役会の平均在任期間7.8yrs

経営陣の近況

Recent updates

Here's Why We're Watching Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation

Nov 15
Here's Why We're Watching Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation

Applied Therapeutics: FDA Stance Change For Advisory Panel Bodes Well For Review

Sep 18

Applied Therapeutics: Pushing Towards FDA Approval

Sep 04

We're Hopeful That Applied Therapeutics (NASDAQ:APLT) Will Use Its Cash Wisely

Aug 01
We're Hopeful That Applied Therapeutics (NASDAQ:APLT) Will Use Its Cash Wisely

Applied Therapeutics: Navigating Challenges In ARI Development For Rare Diseases

May 28

Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible

Feb 16

Is Applied Therapeutics (NASDAQ:APLT) In A Good Position To Deliver On Growth Plans?

Feb 16
Is Applied Therapeutics (NASDAQ:APLT) In A Good Position To Deliver On Growth Plans?

Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?

Nov 13
Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?

We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate

Aug 11
We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate

We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate

May 19
We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate

Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock

Jan 19

Is Applied Therapeutics (NASDAQ:APLT) Using Debt In A Risky Way?

Nov 11
Is Applied Therapeutics (NASDAQ:APLT) Using Debt In A Risky Way?

Here's Why We're Watching Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation

Aug 13
Here's Why We're Watching Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation

Applied Therapeutics trades higher on FDA Fast Track designation for rare metabolic disorder

Jun 17

Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?

May 15
Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?

Independent Director Stacy Kanter Just Bought 100% More Shares In Applied Therapeutics, Inc. (NASDAQ:APLT)

Feb 26
Independent Director Stacy Kanter Just Bought 100% More Shares In Applied Therapeutics, Inc. (NASDAQ:APLT)

How Much Of Applied Therapeutics, Inc. (NASDAQ:APLT) Do Insiders Own?

Feb 18
How Much Of Applied Therapeutics, Inc. (NASDAQ:APLT) Do Insiders Own?

Applied Therapeutics to resume galactosemia study for AT-007

Feb 02

Applied Therapeutics, Inc. (NASDAQ:APLT) Insiders Have Been Selling

Nov 24
Applied Therapeutics, Inc. (NASDAQ:APLT) Insiders Have Been Selling

Applied Therapeutics EPS misses by $0.21

Nov 12

CEO報酬分析

Applied Therapeutics の収益と比較して、Shoshana Shendelman の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$187m

Jun 30 2024n/an/a

-US$161m

Mar 31 2024n/an/a

-US$194m

Dec 31 2023US$9mUS$630k

-US$120m

Sep 30 2023n/an/a

-US$97m

Jun 30 2023n/an/a

-US$73m

Mar 31 2023n/an/a

-US$70m

Dec 31 2022US$3mUS$588k

-US$83m

Sep 30 2022n/an/a

-US$95m

Jun 30 2022n/an/a

-US$105m

Mar 31 2022n/an/a

-US$105m

Dec 31 2021US$2mUS$588k

-US$106m

Sep 30 2021n/an/a

-US$102m

Jun 30 2021n/an/a

-US$104m

Mar 31 2021n/an/a

-US$106m

Dec 31 2020US$5mUS$578k

-US$94m

Sep 30 2020n/an/a

-US$88m

Jun 30 2020n/an/a

-US$69m

Mar 31 2020n/an/a

-US$49m

Dec 31 2019US$12mUS$550k

-US$46m

Sep 30 2019n/an/a

-US$35m

Jun 30 2019n/an/a

-US$28m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$1mUS$500k

-US$17m

報酬と市場: Shoshanaの 総報酬 ($USD 9.49M ) は、 US市場 ($USD 3.18M ) の同規模の企業の平均を上回っています。

報酬と収益: Shoshanaの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Shoshana Shendelman (45 yo)

8.8yrs

在職期間

US$9,493,213

報酬

Dr. Shoshana Shendelman, PhD, has been Director of Applied Therapeutics Inc. since January 2016. Prior to founding Applied, she founded Clearpoint Strategy Group, a boutique life science consulting firm, w...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Shoshana Shendelman
Chair of the Board of Directorsno dataUS$9.49m3.91%
$ 43.8m
Les Funtleyder
CFO, Principal Financial Officer & Independent Directorless than a yearUS$675.15k0.078%
$ 870.2k
Riccardo Perfetti
Chief Medical Officer6.3yrsUS$3.04m0.14%
$ 1.6m
Constantine Chinoporos
COO & Chief Business Officerless than a yearデータなしデータなし
Catherine Thorpe
Chief Accounting Officer1.4yrsデータなしデータなし
Corwin Hooks
Chief Commercial Officerless than a yearデータなしデータなし

1.0yrs

平均在職期間

57.5yo

平均年齢

経験豊富な経営陣: APLTの経営陣は 経験豊富 とはみなされません ( 1年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称ポジション在職期間報酬所有権
Shoshana Shendelman
Chair of the Board of Directors8.8yrsUS$9.49m3.91%
$ 43.8m
Les Funtleyder
CFO, Principal Financial Officer & Independent Director8.4yrsUS$675.15k0.078%
$ 870.2k
Joel Marcus
Independent Director7.8yrsUS$85.65k0.39%
$ 4.4m
Jay Skyler
Independent Director5.6yrsUS$92.53k0.017%
$ 192.5k
Lawrence Steinman
Member of Scientific Advisory Boardno dataデータなしデータなし
Teena Lerner
Lead Independent Director7.7yrsUS$88.78k0.052%
$ 581.6k
Stacy Kanter
Independent Director5.5yrsUS$94.40k0.054%
$ 606.3k
Gregg Stone
Member of Scientific Advisory Boardno dataデータなしデータなし
Donald Landry
Chairman of Scientific Advisory Boardno dataデータなしデータなし
Donald D'Amico
Member of Scientific Advisory Boardno dataデータなしデータなし
Roy Freeman
Member of Scientific Advisory Boardno dataデータなしデータなし
Roxana Mehran
Member of Scientific Advisory Boardno dataデータなしデータなし

7.8yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: APLTの 取締役会 は 経験豊富 であると考えられます ( 7.8年の平均在任期間)。